Related Experiment Videos

Epigenetic targeting in breast cancer: therapeutic impact and future direction

M B Lustberg1, B Ramaswamy

  • 1Division of Hematology and Oncology, Comprehensive Cancer Center, The Ohio State University Medical Center, USA.

Drug News & Perspectives
|November 6, 2009
PubMed

Insights

Epigenetic changes, like DNA methylation, drive breast cancer progression. Understanding these reversible changes offers new therapeutic and diagnostic strategies for breast cancer treatment.

Area of Science:

  • Oncology
  • Molecular Biology
  • Epigenetics

Background:

  • Breast cancer development involves genetic and epigenetic alterations.
  • Epigenetics refers to heritable gene expression changes without altering DNA sequence.
  • DNA methylation and histone modifications are key epigenetic mechanisms in cancer.

Purpose of the Study:

  • To explore the role of epigenetic modifications in breast carcinogenesis.
  • To highlight the potential of targeting epigenetic changes for cancer therapy.
  • To identify novel diagnostic and prognostic tools based on epigenetic alterations.

Main Methods:

  • Review of scientific literature on breast cancer epigenetics.
  • Analysis of gene expression patterns related to methylation and histone modification.
  • Investigation of histone deacetylase inhibitors (HDIs) in breast cancer treatment.

Main Results:

  • Specific genes crucial for proliferation and metastasis are frequently methylated in breast neoplasms.
  • Histone deacetylase inhibitors show promise as synergistic agents in breast cancer therapy.
  • Epigenetic modifications are implicated in various stages of breast cancer.

Conclusions:

  • Epigenetic mechanisms, particularly DNA methylation and histone modifications, are central to breast cancer.
  • The reversible nature of epigenetic changes presents opportunities for novel therapeutic interventions.
  • Targeting epigenetic pathways may lead to improved diagnostic and prognostic markers for breast cancer.

Related Concept Videos

Targeted Cancer Therapies02:57

Targeted Cancer Therapies

The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against specific...
Targeted Cancer Therapies02:57

Targeted Cancer Therapies

The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against specific...
Mitogens and the Cell Cycle02:38

Mitogens and the Cell Cycle

Mitogens and their receptors play a crucial role in controlling the progression of the cell cycle. However, the loss of mitogenic control over cell division leads to tumor formation. Therefore, mitogens and mitogen receptors play an important role in cancer research. For instance, the epidermal growth factor (EGF) - a type of mitogen and its transmembrane receptor (EGFR), decides the fate of the cell's proliferation. When EGF binds to EGFR, a member of the ErbB family of tyrosine kinase...
Pharmacogenetics of Drug Targets: β₂-Adrenergic Receptors, Apo E, Thymidylate Synthase01:11

Pharmacogenetics of Drug Targets: β₂-Adrenergic Receptors, Apo E, Thymidylate Synthase

Genetic polymorphisms in drug targets have emerged as critical determinants of interindividual variability in drug response and toxicity. Pharmacogenomic investigations increasingly focus on identifying these variations to personalize and optimize therapeutic interventions. A drug target may be a receptor, enzyme, or signaling protein involved in pharmacologic responses or disease-related pathways. While early pharmacogenetic studies focused primarily on drug metabolism, current research...
Epigenetic Regulation01:37

Epigenetic Regulation

Epigenetic changes alter the physical structure of the DNA without changing the genetic sequence and often regulate whether genes are turned on or off. This regulation ensures that each cell produces only proteins necessary for its function. For example, proteins that promote bone growth are not produced in muscle cells. Epigenetic mechanisms play an essential role in healthy development. Conversely, precisely regulated epigenetic mechanisms are disrupted in diseases like cancer.
X-chromosome...
Epigenetic Regulation01:46

Epigenetic Regulation

Epigenetic mechanisms play an essential role in healthy development. Conversely, precisely regulated epigenetic mechanisms are disrupted in diseases like cancer.